Nasal blockage and urinary leukotriene E4 concentration in patients with seasonal allergic rhinitis (Q42441558)

31 October 2017

title

Nasal blockage and urinary leukotriene E4 concentration in patients with seasonal allergic rhinitis (English)

1 reference

31 October 2017

Higashi N

1

1 reference

31 October 2017

Taniguchi M

2

1 reference

31 October 2017

Mita H

3

1 reference

31 October 2017

Ishii T

4

1 reference

31 October 2017

Akiyama K

5

1 reference

31 October 2017

language of work or name

1 reference

1 June 2003

1 reference

31 October 2017

1 reference

31 October 2017

volume

58

1 reference

31 October 2017

issue

6

1 reference

31 October 2017

page(s)

476-480

1 reference

Allergic rhinitis and its impact on asthma

31 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00159.X

The role of leukotrienes in allergic rhinitis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00159.X

Behavior and clinical relevance of histamine and leukotrienes C4 and B4 in grass pollen-induced rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00159.X

The leukotriene D4-receptor antagonist, ICI 204,219, relieves symptoms of acute seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00159.X

Allergen-stimulated release of thromboxane A2 and leukotriene E4 in humans. Effect of indomethacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00159.X

Effects of budesonide and fluticasone propionate in a placebo-controlled study on symptoms and quality of life in seasonal allergic rhinitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00159.X

Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00159.X

No involvement of interleukin-5 or eosinophils in experimental allergic rhinitis in guinea pigs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00159.X

Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00159.X

Urinary Excretion of Leukotriene E4and 11-dehydro-Thromboxane B2in Response to Bronchial Provocations with Allergen, Aspirin, Leukotriene D4, and Histamine in Asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00159.X

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00159.X

Urinary Leukotriene E4Concentrations Increase after Aspirin Challenge in Aspirin-sensitive Asthmatic Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00159.X

Efficient method for the quantitation of urinary leukotriene E4: extraction using an Empore C18 disk cartridge

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00159.X

21 January 2018

One airway, one disease

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00159.X

7 January 2021

Inflammatory mediators in late antigen-induced rhinitis

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00159.X

7 January 2021

Mediators of nasal blockage in allergic rbtis

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00159.X

7 January 2021

Reduced Allergen-Induced Nasal Congestion and Leukotriene Synthesis with an Orally Active 5-Lipoxygenase Inhibitor

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00159.X

7 January 2021

Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00159.X

7 January 2021

Urinary excretion of leukotriene E4 and 11-dehydrothromboxane B2 in patients with spontaneous asthma attacks

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00159.X

7 January 2021

Urinary leukotriene E4 after antigen challenge and in acute asthma and allergic rhinitis

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00159.X

7 January 2021

Soluble markers of allergic inflammation

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00159.X

7 January 2021

Increased urinary excretion of the prostaglandin D2 metabolite 9 alpha, 11 beta-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00159.X

7 January 2021

Urinary eosinophil protein X in children with atopic asthma: a useful marker of antiinflammatory treatment

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00159.X

7 January 2021

Montelukast, a leukotriene receptor antagonist, reduces the concentration of leukotrienes in the respiratory tract of children with persistent asthma

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00159.X

7 January 2021

10.1034/J.1398-9995.2003.00159.X

Identifiers

DOI

1 reference

31 October 2017

1 reference